Literature DB >> 28251683

Limb remote ischaemic postconditioning-induced elevation of fibulin-5 confers neuroprotection to rats with cerebral ischaemia/reperfusion injury: Activation of the AKT pathway.

Wei Zhang1, Ye Wang2, Guorong Bi1.   

Abstract

Limb remote ischaemic postconditioning (RIPostC) is an effective and well-acknowledged treatment for brain ischaemia injury. The present study aimed to evaluate the role of fibulin-5 in the neuroprotection of RIPostC against cerebral ischaemia/reperfusion (I/R) injury in rats. The middle cerebral artery occlusion (MCAO) model was established in rats and then RIPostC was carried out by three cycles of 10 minutes occlusion/10 minutes release of the bilateral femoral artery at the beginning of the reperfusion. To downregulate the fibulin-5 level, fibulin-5 siRNA was injected into the lateral ventricle 24 hours before MCAO. According to our present study, RIPostC attenuated cerebral I/R injury by decreasing infarct volume, improving neurobehavioral score and suppressing blood brain barrier (BBB) leakage. Moreover, the mRNA and protein levels of fibulin-5 were upregulated by RIPostC at 24 hours and 72 hours after reperfusion. Downregulation of fibulin-5 attenuated the neuroprotection of RIPostC. Finally, the result showed that fibulin-5 was upregulated by RIPostC via activation of the PI3K/AKT pathway. Taken together, these results provide evidence that upregulation of fibulin-5 is involved in the beneficial effect of RIPostC against cerebral I/R injury.
© 2017 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  PI3K/AKT; cerebral ischaemia/reperfusion; fibulin-5; neuroprotection; remote ischaemic postconditioning

Mesh:

Substances:

Year:  2017        PMID: 28251683     DOI: 10.1111/1440-1681.12742

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  9 in total

Review 1.  Advances in intervention methods and brain protection mechanisms of in situ and remote ischemic postconditioning.

Authors:  Jian-Hui Guo; Li-Yan Li; Chun-Yan Li; Wei Ma; Kuang-Pin Liu; Jin-Wei Yang; Xian-Bin Wang; Zhen Wu; Tong Zhang; Jia-Wei Wang; Wei Liu; Jie Liu; Yu Liang; Xing-Kui Zhang; Jun-Jun Li
Journal:  Metab Brain Dis       Date:  2020-10-12       Impact factor: 3.584

2.  The underlying mechanisms involved in the protective effects of ischemic postconditioning.

Authors:  Rong Xie; Jinquan Li; Heng Zhao
Journal:  Cond Med       Date:  2018

Review 3.  Limb Remote Ischemic Conditioning: Mechanisms, Anesthetics, and the Potential for Expanding Therapeutic Options.

Authors:  Gangling Chen; Mrugesh Thakkar; Christopher Robinson; Sylvain Doré
Journal:  Front Neurol       Date:  2018-02-06       Impact factor: 4.003

Review 4.  Potential Applications of Remote Limb Ischemic Conditioning for Chronic Cerebral Circulation Insufficiency.

Authors:  Jiulin You; Liangshu Feng; Liyang Bao; Meiying Xin; Di Ma; Jiachun Feng
Journal:  Front Neurol       Date:  2019-05-03       Impact factor: 4.086

Review 5.  Progress of Research on Exosomes in the Protection Against Ischemic Brain Injury.

Authors:  Xianhui Kang; Ziyi Zuo; Wandong Hong; Hongli Tang; Wujun Geng
Journal:  Front Neurosci       Date:  2019-10-29       Impact factor: 4.677

6.  DHA Attenuates Hypoxia/Reoxygenation Injury by Activating SSeCKS in Human Cerebrovascular Pericytes.

Authors:  Yanli Yu; Haibin Fang; Zhen Qiu; Zhongyuan Xia; Bin Zhou
Journal:  Neurochem Res       Date:  2019-11-27       Impact factor: 3.996

Review 7.  Effects of Remote Ischemic Conditioning on Cerebral Hemodynamics in Ischemic Stroke.

Authors:  Chen Qin; Xiuli Yan; Hang Jin; Ruyi Zhang; Yaode He; Xin Sun; Yihe Zhang; Zhen-Ni Guo; Yi Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-23       Impact factor: 2.570

8.  Preclinical evidence of remote ischemic conditioning in ischemic stroke, a metanalysis update.

Authors:  Coral Torres-Querol; Manuel Quintana-Luque; Gloria Arque; Francisco Purroy
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

9.  miR-374 improves cerebral ischemia reperfusion injury by targeting Wnt5a.

Authors:  Fangyuan Xing; Yongrong Liu; Ruifang Dong; Ye Cheng
Journal:  Exp Anim       Date:  2020-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.